Redmond Asset Management, LLC Lantern Pharma Inc. Transaction History

Redmond Asset Management, LLC

$305 Million
Q3 2024

A detailed history of Redmond Asset Management, LLC transactions in Lantern Pharma Inc. stock. As of the latest transaction made, Redmond Asset Management, LLC holds 38,920 shares of LTRN stock, worth $137,776. This represents 0.05% of its overall portfolio holdings.

Number of Shares

38,920

Previous 39,635 1.8%

Holding current value

$137,776

Previous $185,000 23.24%

% of portfolio

0.05%

Previous 0.06%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$3.42 - $4.83 $2,445 - $3,453	-715 Reduced 1.8%	38,920 $142,000
Q2 2024 Aug 09, 2024	SELL	$3.91 - $9.51 $3,233 - $7,864	-827 Reduced 2.04%	39,635 $185,000
Q1 2024 May 07, 2024	SELL	$3.73 - $10.65 $746 - $2,130	-200 Reduced 0.49%	40,462 $356,000
Q4 2023 Feb 12, 2024	SELL	$2.48 - $4.39 $14,493 - $25,655	-5,844 Reduced 12.57%	40,662 $174,000
Q3 2023 Oct 24, 2023	SELL	$3.41 - $5.51 $334 - $539	-98 Reduced 0.21%	46,506 $158,000
Q2 2023 Aug 09, 2023	SELL	$4.56 - $6.02 $11,787 - $15,561	-2,585 Reduced 5.26%	46,604 $262,000
Q1 2023 May 03, 2023	SELL	$4.3 - $6.2 $5,091 - $7,340	-1,184 Reduced 2.35%	49,189 $237,000
Q4 2022 Feb 06, 2023	BUY	$4.19 - $6.04 $3,649 - $5,260	871 Added 1.76%	50,373 $304,000
Q3 2022 Nov 10, 2022	SELL	$4.59 - $6.5 $743 - $1,053	-162 Reduced 0.33%	49,502 $237,000
Q2 2022 Aug 10, 2022	SELL	$4.82 - $7.45 $621 - $961	-129 Reduced 0.26%	49,664 $284,000
Q1 2022 May 03, 2022	BUY	$5.6 - $8.22 $3,393 - $4,981	606 Added 1.23%	49,793 $356,000
Q4 2021 Feb 04, 2022	BUY	$7.11 - $11.04 $12,406 - $19,264	1,745 Added 3.68%	49,187 $393,000
Q3 2021 Oct 22, 2021	BUY	$10.53 - $14.93 $20,449 - $28,994	1,942 Added 4.27%	47,442 $530,000
Q2 2021 Aug 11, 2021	BUY	$12.94 - $19.89 $6,586 - $10,124	509 Added 1.13%	45,500 $664,000
Q1 2021 May 06, 2021	BUY	$14.34 - $21.92 $645,170 - $986,202	44,991 New	44,991 $816,000

Others Institutions Holding LTRN

# of Institutions

Shares Held

1.29M

Call Options Held

39.8K

Put Options Held

6.1K

View Full List

About Lantern Pharma Inc.

Ticker LTRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 10,830,900
Market Cap $38.3M
Description
Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...

More about LTRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Redmond Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redmond Asset Management, LLC with notifications on news.

Account

Redmond Asset Management, LLC Lantern Pharma Inc. Transaction History